Time in range: How to measure it, how to report it, and its practical application in clinical decision-making

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667 · see citing works

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

(1998) · The Lancet · doi:10.1016/s0140-6736(98)07019-6 · Cited by 20,023 · see citing works

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419 · see citing works

Effects of Intensive Glucose Lowering in Type 2 Diabetes

(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888 · see citing works

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · see citing works

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,032 · cited 2× · see citing works

International consensus on use of continuous glucose monitoring

Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069 · see citing works

Translating the A1C assay into estimated average glucose values

Nathan, D. M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., Heine, R. J., & for the A1c-Derived Average Glucose (ADAG) Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0545 · Cited by 1,812 · see citing works

Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive Therapy

(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534 · see citing works

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

Whitmer, R. A. (2009) · JAMA · doi:10.1001/jama.2009.460 · Cited by 1,128 · see citing works

9. Pharmacologic Approaches to Glycemic Treatment: <i>Standards of Medical Care in Diabetes—2020</i>

American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s009 · Cited by 914 · see citing works

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials

Beck, R. W., Bergenstal, R. M., Riddlesworth, T. D., Kollman, C., Li, Z., Brown, A. S., & Close, K. L. (2019) · Diabetes Care · doi:10.2337/dc18-1444 · Cited by 793 · see citing works

6. Glycemic Targets: <i>Standards of Medical Care in Diabetes—2020</i>

American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s006 · Cited by 744 · see citing works

Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring

Bergenstal, R. M., Beck, R. W., Close, K. L., Grunberger, G., Sacks, D. B., Kowalski, A., Brown, A. S., Heinemann, L., Aleppo, G., Ryan, D. B., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1581 · Cited by 684 · see citing works

Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: A joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes

International Hypoglycaemia Study Group (2017) · Diabetes Care · doi:10.2337/dc16-2215 · Cited by 608 · see citing works

Glycaemic variability in diabetes: clinical and therapeutic implications

Ceriello, A., Monnier, L., & Owens, D. (2019) · The Lancet Diabetes &amp; Endocrinology · doi:10.1016/s2213-8587(18)30136-0 · Cited by 588 · see citing works

Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level.

Temelkova-Kurktschiev, T. S., Koehler, C., Henkel, E., Leonhardt, W., Fuecker, K., & Markolf Hanefeld, E. (2000) · Diabetes Care · doi:10.2337/diacare.23.12.1830 · Cited by 543 · see citing works

Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes

Lu, J., Ma, X., Zhou, J., Zhang, L., Mo, Y., Ying, L., Lu, W., Zhu, W., Bao, Y., Vigersky, R. A., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1131 · Cited by 517 · see citing works

Diabetes-Related Complications, Glycemic Control, and Falls in Older Adults

Schwartz, A. V., Vittinghoff, E., Sellmeyer, D. E., Feingold, K. R., de Rekeneire, N., Strotmeyer, E. S., Shorr, R. I., Vinik, A. I., Odden, M. C., Park, S. W., et al. (2008) · Diabetes Care · doi:10.2337/dc07-1152 · Cited by 482 · see citing works

The relationships between time in range, hyperglycemia metrics, and HbA1c

Beck, R. W., Bergenstal, R. M., Cheng, P., Kollman, C., Carlson, A. L., Johnson, M. L., & Rodbard, D. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818822496 · Cited by 479 · see citing works

The relationship of hemoglobin A1C to time-in-range in patients with diabetes

Vigersky, R. A., & McMahon, C. (2019) · Diabetes Technology &amp; Therapeutics · doi:10.1089/dia.2018.0310 · Cited by 464 · see citing works

The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: Post hoc epidemiological analysis of the ACCORD study

Miller, M. E., Bonds, D. E., Gerstein, H. C., Seaquist, E. R., Bergenstal, R. M., Calles-Escandon, J., Childress, R. D., Craven, T. E., Cuddihy, R. M., Dailey, G., et al. (2010) · BMJ · doi:10.1136/bmj.b5444 · Cited by 429 · see citing works

Standardizing clinically meaningful outcome measures beyond HbA1c for type 1 diabetes: a consensus report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange

Agiostratidou, G., Anhalt, H., Ball, D., Blonde, L., Gourgari, E., Harriman, K. N., Kowalski, A. J., Madden, P., McAuliffe-Fogarty, A. H., McElwee-Malloy, M., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1624 · Cited by 397 · see citing works

Studies of an unusual hemoglobin in patients with diabetes mellitus

Rahbar, S., Blumenfeld, O. O., & Ranney, H. M. (1969) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(69)90685-8 · Cited by 394 · see citing works

Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

The International Hypoglycaemia Study Group (2016) · Diabetologia · doi:10.1007/s00125-016-4146-6 · Cited by 362 · see citing works

Metrics for glycaemic control - from HbA1c to continuous glucose monitoring

Kovatchev, B. P. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.3 · Cited by 272 · see citing works

HbA1c and Risk of Severe Hypoglycemia in Type 2 Diabetes

Lipska, K. J., Warton, E. M., Huang, E. S., Moffet, H. H., Inzucchi, S. E., Krumholz, H. M., & Karter, A. J. (2013) · Diabetes Care · doi:10.2337/dc13-0610 · Cited by 250 · see citing works

A View Beyond HbA1c: Role of Continuous Glucose Monitoring

Chehrehgosha, H., Khamseh, M. E., Malek, M., Hosseinpanah, F., & Ismail‐Beigi, F. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0619-1 · Cited by 240 · see citing works

Prevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based Studies

Edridge, C. L., Dunkley, A. J., Bodicoat, D. H., Rose, T. C., Gray, L. J., Davies, M. J., & Khunti, K. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126427 · Cited by 230 · see citing works

Association between hypoglycaemic events and fall‐related fractures in Medicare‐covered patients with type 2 diabetes

Johnston, S. S., Conner, C., Aagren, M., Ruiz, K., & Bouchard, J. R. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01583.x · Cited by 226 · see citing works

The association of severe hypoglycemia with incident cardiovascular events and mortality in adults with type 2 diabetes

Lee, A. K., Warren, B., Lee, C. J., McEvoy, J. W., Matsushita, K., Huang, E. S., Sharrett, A. R., Coresh, J., & Selvin, E. (2018) · Diabetes Care · doi:10.2337/dc17-1669 · Cited by 226 · see citing works

Self-reported hypoglycemia and impact on quality of life and depression among adults with type 2 diabetes mellitus.

Green, A. J., Fox, K., & Grandy, S. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.01.002 · Cited by 124 · see citing works

Glycemic Variability: Risk Factors, Assessment, and Control

Kovatchev, B. P. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819826111 · Cited by 111 · see citing works

Utilizing the Ambulatory Glucose Profile to Standardize and Implement Continuous Glucose Monitoring in Clinical Practice

Johnson, M. L., Martens, T. W., Criego, A. B., Carlson, A. L., Simonson, G. D., & Bergenstal, R. M. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0034 · Cited by 104 · see citing works

Time in Range, as a Novel Metric of Glycemic Control, Is Reversely Associated with Presence of Diabetic Cardiovascular Autonomic Neuropathy Independent of HbA1c in Chinese Type 2 Diabetes

Guo, Q., Zang, P., Xu, S.-Y., Song, W., Zhang, Z., Liu, C., Guo, Z., Chen, J., Lu, B., Gu, P., et al. (2020) · Journal of Diabetes Research · doi:10.1155/2020/5817074 · Cited by 75 · see citing works

Laboratory Diagnosis of HbA1c: A Review

Chauhan, N. (2017) · Journal of Nanomedicine Research · doi:10.15406/jnmr.2017.05.00120 · Cited by 74 · see citing works

A history of HbA 1c through Clinical Chemistry and Laboratory Medicine

Gillery, P. (2012) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0548 · Cited by 73 · see citing works

The effects of glucose fluctuation on cognitive function and QOL: the functional costs of hypoglycaemia and hyperglycaemia among adults with type 1 or type 2 diabetes.

Cox, D. J., Gonder-Frederick, L. A., McCall, A. L., Kovatchev, B. P., & Clarke, W. (2002) · PubMed · Cited by 59 · see citing works

Liberating A1C goals in older adults may not protect against the risk of hypoglycemia

Munshi, M. N., Slyne, C., Segal, A. R., Saul, N., Lyons, C., & Weinger, K. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.02.014 · Cited by 50 · see citing works

Glucose Variables in Type 1 Diabetes Studies With Dapagliflozin: Pooled Analysis of Continuous Glucose Monitoring Data From DEPICT-1 and -2

Mathieu, C., Dandona, P., Phillip, M., Oron, T., Lind, M., Hansen, L., THOREN, F. A., Xu, J., Langkilde, A. M., & on behalf of the DEPICT-1 and DEPICT-2 Investigators (2019) · Diabetes Care · doi:10.2337/dc18-1983 · Cited by 48 · see citing works

Hemoglobin A1c determination in the A1C-Derived Average Glucose (ADAG) study

Lenters‐Westra, E., & Slingerland, R. J. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.322 · Cited by 26 · see citing works

ADAG Study Group Data Links A1C Levels with Empirically Measured Blood Glucose Values - New Treatment Guidelines Will Now be Needed

Klonoff, D. C. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814529638 · Cited by 24 · see citing works

Standardising HbA1c-based diabetes diagnosis: opportunities and challenges

Jia, W. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2016.1133299 · Cited by 24 · see citing works

Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections

Sofizadeh, S., Imberg, H., Ólafsdóttir, A. F., Ekelund, M., Dahlqvist, S., Hirsch, I. B., Filipsson, K., Åhrén, B., Sjöberg, S., Tuomilehto, J., et al. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-00692-1 · Cited by 22 · see citing works

The importance of postprandial hyperglycaemia in development of cardiovascular disease in people with diabetes: point.

Haffner, S. M. (2001) · PubMed · Cited by 17 · see citing works

Application of ensemble machine learning algorithms on lifestyle factors and wearables for cardiovascular risk prediction

Huang, W., Ying, T. W., Chin, W. L. C., Baskaran, L., Marcus, O. E. H., Yeo, K. K., & Kiong, N. S. (2022) · Scientific Reports · doi:10.1038/s41598-021-04649-y · Cited by 63 · see citing works

Demographic and Glycemic Factors Linked With Diabetes Distress in Teens With Type 1 Diabetes

Inverso, H., LeStourgeon, L. M., Parmar, A., Bhangui, I., Hughes, B., Straton, E., Alford, M., Streisand, R. M., & Jaser, S. S. (2022) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsac049 · Cited by 26 · see citing works

A Randomized Controlled Trial Using Continuous Glucose Monitoring to Guide Food Choices and Diabetes Self-Care in People with Type 2 Diabetes not Taking Insulin

Martens, T. W., Willis, H. J., Bergenstal, R. M., Kruger, D. F., French, E. K., & Steenkamp, D. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0579 · Cited by 22 · see citing works

Time in range and complications of diabetes: a cross-sectional analysis of patients with Type 1 diabetes

Bezerra, M. F., Neves, C., Neves, J. S., & Carvalho, D. M. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01219-2 · Cited by 21 · see citing works

To What Extent Is HbA1c Associated with Glycemic Variability in Patients with Type 1 Diabetes? A Retrospective, Noninterventional Study

Lazăr, S., Ioniță, I., Reurean‐Pintilei, D., Timar, R. Z., Luca, S. A., & Timar, B. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020450 · Cited by 13 · see citing works

Hypoglycemia in Adults

Lega, I. C., Yale, J.-F., Chadha, A., Paty, B., Roscoe, R., Snider, M., Steier, J., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.08.003 · Cited by 12 · see citing works

Visual acuity time in range: a novel concept to describe consistency in treatment response in diabetic macular oedema

Kozak, I., Pearce, I., Cheung, C. M. G., Machewitz, T., Lambrou, G. N., Molina, D., Suleiman, L., Youssef, H., & Bressler, N. M. (2023) · Eye · doi:10.1038/s41433-023-02507-x · Cited by 11 · see citing works

Impact of Negative or Stigmatizing Messages on Diabetes Outcomes: An Integrative Review

Dickinson, J. K., Posesorski, R. E., Djiovanis, S. G., & Brady, V. J. (2024) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106241232644 · Cited by 10 · see citing works

Impact of allulose on blood glucose in type 2 diabetes: A meta-analysis of clinical trials

Ayesh, H., Suhail, S., & Ayesh, S. K. (2024) · Metabolism Open · doi:10.1016/j.metop.2024.100329 · Cited by 8 · see citing works

Hypoglycemia and glycemic variability of people with type 1 diabetes with lower and higher physical activity loads in free-living conditions using continuous subcutaneous insulin infusion with predictive low-glucose suspend system

Montt‐Blanchard, D., Sánchez, R., Dubois‐Camacho, K., Leppe, J., & Onetto, M. T. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-003082 · Cited by 8 · see citing works

The association between glycaemic variability and sleep quality and quantity in adults with type 1 and type 2 diabetes: A systematic review

Pham, C. T., Ali, A. S., Churilov, L. P., Baqar, S., Hendrieckx, C., O'Neal, D. N., Howard, M. E., & Ekinci, E. I. (2024) · Diabetic Medicine · doi:10.1111/dme.15485 · Cited by 7 · see citing works

Diabetes Self-Care in Older Adults With Type 1 Diabetes Mellitus: How Does Cognition Influence Self-Management

Gjorup, A. L. T., Snoek, F. J., & van Duinkerken, E. (2021) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2021.727029 · Cited by 7 · see citing works

Pilot study in human healthy volunteers on the use of magnetohydrodynamics in needle-free continuous glucose monitoring

Hakala, T. A., Zschaechner, L. K., Vänskä, R. T., Nurminen, T. A., Wardale, M., Morina, J., Boeva, Z. A., Saukkonen, R., Alakoskela, J.-M. I., Pettersson-Fernholm, K., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-21424-9 · Cited by 7 · see citing works

Biotechnology Revolution Shaping the Future of Diabetes Management

Kundnani, N. R., Lolescu, B. M., Dinu, A. R., Berceanu-Vaduva, D. M., Dumitrescu, P., Tamaș, T.-P., Sharma, A., & Popa, M.-D. (2024) · Biomolecules · doi:10.3390/biom14121563 · Cited by 6 · see citing works

Diabetes Mellitus Control and Chronic Kidney Disease

Safaa, M. M. (2023) · American Journal of Chemistry and Pharmacy · doi:10.54536/ajcp.v2i2.1612 · Cited by 6 · see citing works

Control of Type 1 Diabetes Mellitus using Particle Swarm Optimization driven Receding Horizon Controller

Siket, M., Novák, K., Redjimi, H., Tar, J. K., Kovács, L., & Eigner, G. (2021) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2021.10.271 · Cited by 5 · see citing works

Association between continuous glucose monitoring derived metrics and clinical parameters in Indian people living with type 2 diabetes

CHAWLA, P. M., Sowani, A., Parikh, R. M., Gupta, A. S., Kesavadev, J., Gokalani, R. A., Saboo, B., & Chawla, M. S. (2025) · Primary care diabetes · doi:10.1016/j.pcd.2025.06.004 · Cited by 4 · see citing works

Strategies for optimization of hypoglycemia rat models

Zher, L. Y., Kong, E. Q. Z., Raymond, R. E., Jie, Y. Z., & Yap, C. G. (2025) · Animal Models and Experimental Medicine · doi:10.1002/ame2.70045 · Cited by 3 · see citing works

Glycaemic control after connected insulin pen initiation in people living with diabetes: Results from a real‐world setting

Adolfsson, P., Guerci, B., Hartvig, N. V., Kaas, A., Knudsen, N., & Mader, J. K. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70051 · Cited by 3 · see citing works

Time‐in‐range derived from self‐measured blood glucose in people with type 2 diabetes advancing to iGlarLixi : A participant‐level pooled analysis of three phase 3 LixiLan randomized controlled trials

Haluzı́k, M., Al‐Sofiani, M. E., CHENG, A. Y. Y., Lauand, F., Melas‐Melt, L., & Rosenstock, J. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15811 · Cited by 3 · see citing works

Glycemic variability and quality of life outcomes after changing to hybrid closed-loop system in Japanese individuals with type 1 diabetes using a conventional predictive low-glucose suspended insulin pump system

Fuchigami, A., Kojimahara, Y., Yoshikawa, F., Higa, M., Ichijyo, T., Ikehara, K., Uchino, H., & Hirose, T. (2024) · Diabetology International · doi:10.1007/s13340-024-00778-7 · Cited by 2 · see citing works

Clinical perspective on innovative insulin delivery technologies in diabetes management

Kockaya, G., Battelino, T., Petrovski, G., JENDLE, J. H., Sármán, B., Elbarbary, N. S., Gökşen, D., Alharbi, M., Tibet, B., Charaf, A. M., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1308319 · Cited by 2 · see citing works

Digital Technology in the Management and Prevention of Diabetes

(2024) · Frontiers research topics · doi:10.3389/978-2-8325-5649-8 · Cited by 2 · see citing works

EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study

Deters, M. A., Obarčanin, E., Schwender, H. R., & Läer, S. (2021) · Pharmacy · doi:10.3390/pharmacy9030137 · Cited by 2 · see citing works

Trends in Time in Range–Related Publications and Clinical Trials: A Bibliometric Review

Patel, P. M., Abaniel, R. M., Dogra, N., Lo, C. B., Frazzitta, M. A., & Virdi, N. S. (2023) · Diabetes Spectrum · doi:10.2337/ds22-0085 · Cited by 2 · see citing works

Enhancement of Ambulatory Glucose Profile for Decision Assistance and Treatment Adjustments

Satuluri, V. K. R. R., & Ponnusamy, V. (2024) · Diagnostics · doi:10.3390/diagnostics14040436 · Cited by 2 · see citing works

Improvement in Glycemic Metrics With the First and Second Continuous Glucose Monitoring (CGM) Sensor Use in Indian Patients With Type 2 Diabetes Mellitus

Gupta, V. (2025) · Cureus · doi:10.7759/cureus.82061 · Cited by 1 · see citing works

Pyloric botulinum toxin for diabetic gastroparesis: a case of sustained glycaemic improvement

Bugeja, L., Camilleri, L., & Schembri, J. (2025) · European Journal of Case Reports in Internal Medicine · doi:10.12890/2025_005495 · Cited by 1 · see citing works

Relation of time in range to severity of coronary artery disease in patients with type 2 diabetes: A cross-sectional study

Ma, W., Li, J., Shao, X., Yin, X., Xie, C., Wang, F., & Li, Y. (2025) · Open Medicine · doi:10.1515/med-2025-1158 · Cited by 1 · see citing works

Trends in Time in Range–Related Publications and Clinical Trials: A Bibliometric Review

Patel, P. M., Abaniel, R. M., Dogra, N., Lo, C. B., Frazzitta, M. A., & Virdi, N. S. (2023) · doi:10.2337/figshare.22714573

ҮЗДІКСІЗ ГЛИКЕМИЯЛЫҚ МОНИТОРИНГ – ДИАБЕТОЛОГИЯДАҒЫ ЖАҢА ТЕХНОЛОГИЯЛАР (әдеби шолу)

Kaibagarova, I., Мавлюдова, Н. М., Ж.Ж., Н., Овсянникова, А. К., & Kalzhanova, M. (2024) · Farmaciâ Kazahstana · doi:10.53511/pharmkaz.2024.62.25.006

A Quantitative Framework for Evaluating the Performance of Algorithm-Directed Whole-Population Remote Patient Monitoring for Type 1 Diabetes CarePreprint

Kurtzig, J., Ferstad, J. O., Dupenloup, P., Zaharieva, D. P., Maahs, D. M., Prahalad, P., Ramesh Johari, B., Bishop, F. K., Addala, A., & Scheinker, D. (2025) · medRxiv · doi:10.1101/2025.02.03.25321621

Impact of the KARAZ platform's behavioral interventions and incentives on diabetic glycemic control in Saudi Arabia

Alqutub, S. T., & Aljehani, F. (2025) · Digital Health · doi:10.1177/20552076251325987

Important Continuous Glucose Monitoring Attributes for Patients With Type 2 Diabetes

Lai, T. C., Whitley, H. P., Genie, M. G., Eckel, R. H., & Ngorsuraches, S. (2025) · Clinical Diabetes · doi:10.2337/cd25-0047

Additional file 1 of Time in range and complications of diabetes: a cross-sectional analysis of patients with Type 1 diabetes

Bezerra, M. F., Neves, C., Neves, J. S., & Carvalho, D. (2023) · Figshare · doi:10.6084/m9.figshare.24636469

Combined assessment with stress hyperglycemia ratio and time in range: Associations with twenty-eight-day mortality in surgical intensive care unit patients

Liu, S., Cao, B.-G., Ma, Y., Xu, J.-F., Zhou, Q., & Wang, C. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i1.112621

A Quantitative Framework for Evaluating the Performance of Algorithm-Directed Whole-Population Remote Patient Monitoring: Tutorial for Type 1 Diabetes Care

Kurtzig, J., Addala, A., Bishop, F. K., Dupenloup, P., Ferstad, J. O., Ramesh Johari, B., Maahs, D. M., Prahalad, P., Zaharieva, D. P., & Scheinker, D. (2026) · JMIR Diabetes · doi:10.2196/72676

A region-wide hub and spoke approach to standardize and decentralize type 1 diabetes management

Minuto, N., Spacco, G., Siri, G., Leoni, M., Gaiero, A., Corona, M. F., Minghetti, D., Ramenghi, L. A., Pintabona, A., Calevo, M. G., et al. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1763175

Continuous glucose monitoring-based evaluation of percentage coefficient of variation (%CV) as a metric of intraday glycemic variability in South India

Hussain, M. A., Anil Kumar, H., & Lingaiah, M. (2026) · Scientific Reports · doi:10.1038/s41598-026-47067-8

THE ROLE AND CLINICAL SIGNIFICANCE OF CONTINUOUS GLUCOSE MONITORING METRICS İN PREDIABETES

GÜNEYSU, B. Y., & Çotuk, H. B. (2026) · AURUM Journal of Engineering Systems and Architecture · doi:10.53600/ajesa.1861999

Evaluating Time in Range for Visual Acuity and Macular Thickness as Outcome Measures for Randomized Clinical Trials

Kozak, I., Panjwani, M., Wu, R., & Holmes, J. M. (2026) · Translational Vision Science & Technology · doi:10.1167/tvst.15.8.12

Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With Diabetes

Bellido, V., Aguilera, E., Cardona‐Hernandez, R., Díaz-Soto, G., de Villar, N. G. P., César, M. J. P., & Ampudia‐Blasco, F. J. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221088601 · Cited by 39 · see citing works

Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control

Yoo, J. H., & Kim, J. H. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0256 · Cited by 12 · see citing works

Impact of time in range on glycated hemoglobin in patients with diabetes mellitus: a protocol of systematic review

Lima, R. A. D., teixeira, C. R. D. S., Garcia, R. A. C., & Fernandes, D. R. (2021) · Open Science Framework · doi:10.17605/osf.io/nkmzb

The Changing Landscape of Glycemic Targets: Focus on Continuous Glucose Monitoring

Kushner, P. R., & Kruger, D. F. (2020) · Clinical Diabetes · doi:10.2337/cd19-0093 · Cited by 7 · see citing works

Abstract #1185116: Time in range metrics and its association with glycated hemoglobin in routine clinical practice

Chawla, M. S., & CHAWLA, P. M. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.130